Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Invitae Breast and Gyn Cancers Guidelines-Based Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 26 | 19 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 19 | 14 |
|
Hypertrophic Cardiomyopathy NGS Panel Fulgent Genetics United States | 375 | 86 |
|
Cardio-Facio-Cutaneous Syndrome NGS Panel Fulgent Genetics United States | 20 | 6 |
|
Invitae Breast and Gyn Cancers Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 33 | 23 |
|
Invitae Peutz-Jeghers Syndrome Test Labcorp Genetics (formerly Invitae) LabCorp United States | 5 | 1 |
|
Fulgent Genetics United States | 9 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Fulgent Genetics United States | 24 | 11 |
|
Intellectual Disability NGS Panel Fulgent Genetics United States | 1058 | 554 |
|
Comprehensive Cardiovascular NGS Panel Fulgent Genetics United States | 671 | 250 |
|
BRCA1 Hereditary Breast and Ovarian Cancer MGZ Medical Genetics Center Germany | 4 | 1 |
|
BRCA2 Hereditary Breast and Ovarian Cancer MGZ Medical Genetics Center Germany | 4 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.